Uganda has launched a trial of a vaccine against the Sudan strain of the Ebola virus, following an outbreak in the country with three confirmed cases. The first patient, a 32-year-old male nurse, died last week.

Ugandan authorities on Monday began a clinical trial of a vaccine against the Sudan strain of Ebola that has killed one person in the outbreak declared last week. This is the first trial to assess the efficacy of a vaccine against the Sudan strain,

Uganda has begun a trial vaccination programme for the strain of Ebola viral infection that is behind the country's latest outbreak, according to the World Health Organization (WHO), while the number of confirmed cases has risen to three.

In a global first, Uganda’s Ministry of Health, the World Health Organization (WHO) and other partners today launched a first ever vaccine trial for Ebola from the Sudan species of the virus, and at an unprecedented speed for a randomized vaccine trial in an emergency.

Ugandan officials are preparing to deploy a trial vaccine as part of efforts to stem an outbreak of Ebola in the capital, Kampala

This is a critical achievement toward better pandemic preparedness and saving lives when outbreaks occur,” said Dr. Tedros Adhanom Ghebreyesus, WHO Director-General.

GENEVA - Uganda on Monday started the first-ever vaccination trial for the Sudan species of the Ebola virus four days after an outbreak was confirmed, the World Health Organization announced.

Test results on the sick people are pending, and a top WHO official said the outbreak response is proceeding rapidly.